Aim. The aim of this study was to evaluate the association between HCV and lung cancer. Methods. The study included 60 patients who admitted department of chest diseases our hospital for diagnosis of lung cancer. These patients were performed the blood test for HCV before to invasive procedures. Results: Of 60 patients included in this study, 58 (96.7%) were male and 2 (3.3%) were female. There was a statistically no significant difference between patients with Anti-HCV (+) and Anti-HCV (-) for gender and age (p>0.05). We found that anti-HCV antibodies were positive in 3 of 60 (5%) patients with lung cancer. Histologic types of lung cancer were 38.0 % squamous cell cancer, 30.0 % adenocarcinoma, 10.0% undifferentiated, and 21.7% small cell lung cancer. There was a statistically non-significant difference between patients with anti-HCV (+) and anti-HCV (-) for histological type of lung cancer (p>0.05). Conclusions: The development of lung cancer is a multifactorial process, including the environment factors, smoking, certain occupations, and genetic factors. HCV positivity alone may not be sufficient evidence for cause lung cancer. Therefore, there is a need studies that have large numbers of patients with HCV infection and lung cancer patients for this association.